| Stage | AMGN | % of rev | KRYS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $10.4B | 100.00% | $127M | 100.00% | AMGN ×81.40 |
| Gross profit | $7.6B | 73.10% | $120M | 94.07% | KRYS +21.0pp |
| Operating income | $3.7B | 35.79% | $71M | 55.87% | KRYS +20.1pp |
| Pre-tax income | $4.7B | 45.21% | $80M | 62.94% | KRYS +17.7pp |
| Net income | $3.9B | 37.28% | $63M | 49.53% | KRYS +12.2pp |
| Stage | AMGN | KRYS | Gap · A − B |
|---|---|---|---|
| Revenue | $10.4B100.00% | $127M100.00% | AMGN ×81.40 |
| Gross profit | 73.10%$7.6B | 94.07%$120M | KRYS +21.0pp |
| Operating income | 35.79%$3.7B | 55.87%$71M | KRYS +20.1pp |
| Pre-tax income | 45.21%$4.7B | 62.94%$80M | KRYS +17.7pp |
| Net income |
| 37.28%$3.9B |
| 49.53%$63M |
| KRYS +12.2pp |
No shared counterparties.